WallStreetZenWallStreetZen

NASDAQ: BBIO
Bridgebio Pharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for BBIO

Based on 8 analysts offering 12 month price targets for Bridgebio Pharma Inc

Min Forecast
$45.00+34.29%
Avg Forecast
$55.50+65.62%
Max Forecast
$95.00+183.5%

Should I buy or sell BBIO stock?

Based on 8 analysts offering ratings for Bridgebio Pharma Inc.

Strong Buy
Strong Buy
5 analysts 62.5%
Buy
3 analysts 37.5%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although BBIO's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates BBIO as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their BBIO stock forecasts and price targets.

BBIO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-15
lockedlocked$00.00+00.00%2025-03-31
lockedlocked$00.00+00.00%2025-03-24
lockedlocked$00.00+00.00%2025-02-21
lockedlocked$00.00+00.00%2025-02-21
ScotiaBank
Bottom 15%
15
BuyMaintains$52.00+55.18%2025-02-21
Evercore ISI Group
Top 22%
79
BuyMaintains$50.00+49.21%2024-12-23
Bank of America
Bottom 5%
5
Strong BuyMaintains$45.00+34.29%2024-11-25

1 of 1

Forecast return on equity

Is BBIO forecast to generate an efficient return?

Company
-32.36%
Industry
153.19%
Market
81.87%
BBIO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BBIO forecast to generate an efficient return on assets?

Company
51.67%
Industry
36.07%
BBIO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BBIO earnings per share forecast

What is BBIO's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
-$4.00
Avg 2 year Forecast
-$2.66
Avg 3 year Forecast
-$0.48

BBIO revenue forecast

What is BBIO's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$252.9M+13.99%
Avg 2 year Forecast
$538.3M+142.6%
Avg 3 year Forecast
$1.1B+388.32%
BBIO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BBIO revenue growth forecast

How is BBIO forecast to perform vs Biotechnology companies and vs the US market?

Company
66.99%
Industry
65.48%
Market
10.37%
BBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BBIO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BBIO$33.51$55.50+65.62%Strong Buy
MDGL$295.02$388.00+31.52%Buy
CORT$62.90$143.25+127.74%Strong Buy
JAZZ$100.34$188.67+88.03%Strong Buy
RVMD$36.56$70.40+92.56%Strong Buy
View Top Biotech Stocks

Bridgebio Pharma Stock Forecast FAQ

Is Bridgebio Pharma Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: BBIO) stock is to Strong Buy BBIO stock.

Out of 8 analysts, 5 (62.5%) are recommending BBIO as a Strong Buy, 3 (37.5%) are recommending BBIO as a Buy, 0 (0%) are recommending BBIO as a Hold, 0 (0%) are recommending BBIO as a Sell, and 0 (0%) are recommending BBIO as a Strong Sell.

If you're new to stock investing, here's how to buy Bridgebio Pharma stock.

What is BBIO's earnings growth forecast for 2025-2027?

(NASDAQ: BBIO) Bridgebio Pharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.

Bridgebio Pharma's earnings in 2025 is -$535,762,000.On average, 9 Wall Street analysts forecast BBIO's earnings for 2025 to be -$761,172,919, with the lowest BBIO earnings forecast at -$878,671,452, and the highest BBIO earnings forecast at -$599,094,172. On average, 7 Wall Street analysts forecast BBIO's earnings for 2026 to be -$506,168,009, with the lowest BBIO earnings forecast at -$587,682,854, and the highest BBIO earnings forecast at -$300,498,029.

In 2027, BBIO is forecast to generate -$92,051,295 in earnings, with the lowest earnings forecast at -$408,905,546 and the highest earnings forecast at $116,015,062.

What is BBIO's revenue growth forecast for 2025-2027?

(NASDAQ: BBIO) Bridgebio Pharma's forecast annual revenue growth rate of 66.99% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.48%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.37%.

Bridgebio Pharma's revenue in 2025 is $221,902,000.On average, 6 Wall Street analysts forecast BBIO's revenue for 2025 to be $48,106,311,060, with the lowest BBIO revenue forecast at $18,695,541,936, and the highest BBIO revenue forecast at $75,067,450,682. On average, 6 Wall Street analysts forecast BBIO's revenue for 2026 to be $102,383,862,657, with the lowest BBIO revenue forecast at $80,940,475,453, and the highest BBIO revenue forecast at $129,347,284,543.

In 2027, BBIO is forecast to generate $206,086,112,870 in revenue, with the lowest revenue forecast at $149,393,165,723 and the highest revenue forecast at $260,387,247,857.

What is BBIO's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: BBIO) forecast ROA is 51.67%, which is higher than the forecast US Biotechnology industry average of 36.07%.

What is BBIO's Price Target?

According to 8 Wall Street analysts that have issued a 1 year BBIO price target, the average BBIO price target is $55.50, with the highest BBIO stock price forecast at $95.00 and the lowest BBIO stock price forecast at $45.00.

On average, Wall Street analysts predict that Bridgebio Pharma's share price could reach $55.50 by Apr 15, 2026. The average Bridgebio Pharma stock price prediction forecasts a potential upside of 65.62% from the current BBIO share price of $33.51.

What is BBIO's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: BBIO) Bridgebio Pharma's current Earnings Per Share (EPS) is -$2.88. On average, analysts forecast that BBIO's EPS will be -$4.00 for 2025, with the lowest EPS forecast at -$4.62, and the highest EPS forecast at -$3.15. On average, analysts forecast that BBIO's EPS will be -$2.66 for 2026, with the lowest EPS forecast at -$3.09, and the highest EPS forecast at -$1.58. In 2027, BBIO's EPS is forecast to hit -$0.48 (min: -$2.15, max: $0.61).

What is BBIO's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: BBIO) forecast ROE is -32.36%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.